Company news
China Meheco Group Co., Ltd. news in 2025
China Meheco Group Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Resolutions of the 34th Meeting of the 9th Board of Directors
December 30, 2025
Announcement on Obtaining Drug Registration Approval by Subsidiary
December 24, 2025
Announcement on Resolutions of the 33rd Meeting of the 9th Board of Directors
November 24, 2025
Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2025
November 12, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 4, 2025
Announcement on Prospective Winning of the Subsidiary in the 11th National Centralized Drug Procurement
October 28, 2025
Full Text of Report for Q3 2025
October 27, 2025
Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional Investors
October 10, 2025
Announcement on Providing Guarantee for Wholly-owned Subsidiaries
September 19, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 3, 2025
Announcement on Resolutions of the 31st Meeting of the 9th Board of Directors
August 27, 2025
Announcement on Subsidiary's APIs Obtaining CEP Certificate
August 13, 2025
Announcement on Resolutions of the 14th Meeting of the 9th Board of Supervisors
August 8, 2025
Notice on Convening the 5th Extraordinary General Meeting in 2025
July 23, 2025
Announcement on Resignation of Directors and General Managers
July 17, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
July 11, 2025
Announcement on Implementation of Final Dividend Distribution for 2024
July 2, 2025
Announcement on Subsidiary Obtaining Notice of Approval for Drug Supplement Application
June 27, 2025
Announcement on Waiver of Preemptive Right for 24% Equity of Joint-stock Companies
June 24, 2025
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2025
June 23, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
May 28, 2025
Announcement on Reply to Letter of Regulation Regarding the Acquisition of Related Parties' Assets
May 26, 2025
Announcement on Retirement and Resignation of Director
May 16, 2025